|
|
|
| Current status and influencing factors of comorbidity of hypertension, diabetes mellitus and dyslipidemia among residents in Jiangbei District |
| YUAN Fang, ZHANG Aiping
|
| Jiangbei District Center for Disease Control and Prevention, Ningbo, Zhejiang 315020, China |
|
|
|
|
Abstract Objective To analyze the current status and influencing factors of comorbidity of hypertension, diabetes mellitus and dyslipidemia among residents aged 35-75 years in Jiangbei District, Ningbo City, Zhejiang Province, so as to provide evidence for optimizing the hierarchical and tiered management strategy for the integrated management of these diseases and rationally allocating health resources. Methods From 2019 to 2025, permanent residents aged 35-75 years in Jiangbei District were selected as study participants using a multi-stage stratified random cluster sampling method. Gender, age, body mass index (BMI), waist circumference, blood pressure and blood biochemical indicators were collected through questionnaires, physical examinations and laboratory tests. The prevalence of comorbidity of hypertension, diabetes mellitus and dyslipidemia was analyzed, and the standardized comorbidity prevalence was calculated using the data from the Seventh National Population Census in 2020. A multivariable logistic regression model was used to analyze influencing factors of the comorbidity of hypertension, diabetes mellitus and dyslipidemia. Results A total of 12 616 residents were surveyed, including 4 992 males (39.57%) and 7 624 females (60.43%). The majority of residents were aged 60-<70 years, with 5 379 individuals (42.64%). A total of 1 044 residents were identified with the comorbidity of hypertension, diabetes mellitus and dyslipidemia, with a prevalence of 8.27% and the standardized prevalence of 6.17%. Multivariable logistic regression analysis showed that age (60-<70 years, OR=1.673, 95%CI: 1.425-1.964; 70-75 years, OR=1.586, 95%CI: 1.310-1.921), smoking (OR=1.301, 95%CI: 1.072-1.578), BMI (overweight, OR=1.458, 95%CI: 1.244-1.709; obesity, OR=1.919, 95%CI: 1.547-2.381) and central obesity (OR=1.509, 95%CI: 1.294-1.760) were influencing factors for the comorbidity of hypertension, diabetes mellitus and dyslipidemia. Conclusion The prevalence of comorbidity of hypertension, diabetes mellitus and dyslipidemia among residents aged 35-75 years in Jiangbei District was relatively high, and residents aged 60-75 years, smokers, people with overweight or obesity, and those with central obesity had a higher risk of comorbidity of hypertension, diabetes mellitus and dyslipidemia.
|
|
Received: 29 May 2026
Revised: 27 July 2026
Published: 21 August 2026
|
|
|
|
|
|
[1] 国家心血管病中心,中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2024概要[J].中国循环杂志,2025,40(6):521-559.
[2] Wang W H,Liu Y X,Yuan D F,et al.Association between metabolic multimorbidity and the risk of cardiovascular disease,kidney disease,and mortality:longitudinal evidence from CHARLS(2011-2020)[J/OL].Public Health,2025,249[2026-07-27].https://doi.org/10.1016/j.puhe.2025.106020.
[3] 周国营,邢丽丽,苏颖,等.35~75岁居民心血管病高危风险预测模型研究[J].预防医学,2025,37(1):12-16.
[4] 孙洪峡,张迎怡,王金萍.天津市北辰区35~75岁人群血脂异常患病状况及影响因素[J].中国慢性病预防与控制,2025,33(5):381-384.
[5] 北京高血压防治协会,中国老年学和老年医学学会,北京市社区卫生协会,等.成人高血压合并2型糖尿病和血脂异常基层防治中国专家共识(2024年版)[J].中国全科医学,2024,27(28):3453-3475,3482.
[6] Skou S T,Mair F S,Fortin M,et al.Multimorbidity[J/OL].Nat Rev Dis Primers,2022,8[2026-07-27].https://doi.org/10.1038/s41572-022-00376-4.
[7] 周梦怡,苏丹婷,何梦洁,等.浙江省35~75岁居民身体圆度指数与心血管代谢性疾病共病风险的关联性研究[J].现代预防医学,2025,52(10):1748-1753,1767.
[8] Lv J,Yu C Q,Guo Y,et al.Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population[J].J Am Coll Cardiol,2017,69(9):1116-1125.
[9] 中国营养学会肥胖防控分会,中国营养学会临床营养分会,中华预防医学会行为健康分会,等.中国居民肥胖防治专家共识[J].中华流行病学杂志,2022,43(5):609-626.
[10] 中国高血压防治指南修订委员会,高血压联盟(中国),中国医疗保健国际交流促进会高血压分会,等.中国高血压防治指南(2024年修订版)[J].中华高血压杂志,2024,32(7):603-700.
[11] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.
[12] 王增武,刘静,李建军,等.中国血脂管理指南(2023年)[J].中国循环杂志,2023,38(3):237-271.
[13] 王凤华,魏茂提,杨宁,等.天津市35~75岁居民高血压、糖尿病和血脂异常共病现况及影响因素分析[J].中华流行病学杂志,2024,45(9):1224-1232.
[14] 陈月珍,彭秀卿,陶凯伦,等.厦门市海沧区居民高血压患病、知晓、治疗和控制状况及影响因素[J].海峡预防医学杂志,2025,31(6):94-97.
[15] 关方旭,何宇纳,苏畅,等.2009—2023年中国十省(自治区)成年居民慢性病共病分布现况及流行趋势[J].卫生研究,2024,53(6):887-892.
[16] 何志伟,胡欣,余静雯,等.细胞衰老与2型糖尿病[J].中华内分泌代谢杂志,2023,39(6):532-537.
[17] 叶婷婷,邵英,余彬,等.老年人不健康生活方式与高血压、糖尿病和血脂异常的关联研究[J].中华流行病学杂志,2024,45(3):385-392.
[18] 庞元捷,余灿清,郭彧,等.中国成年人行为生活方式与主要慢性病的关联——来自中国慢性病前瞻性研究的证据[J].中华流行病学杂志,2021,42(3):369-375.
[19] Reaven G,Tsao P S.Insulin resistance and compensatory hyperinsulinemia:the key player between cigarette smoking and cardiovascular disease?[J].J Am Coll Cardiol,2003,41(6):1044-1047.
[20] 吴梦怡,胡劲松,黄霜,等.湖南省30岁及以上社区居民高血压、糖尿病、高血脂共病的影响因素分析[J].预防医学,2021,33(2):157-161.
[21] 胡建功,张世伟,游凯,等.北京市某区居民高血压、糖尿病和血脂异常共病调查[J].预防医学,2026,38(6):614-617,621.
[22] 国家卫生健康委员会肥胖症诊疗指南编写委员会.肥胖症诊疗指南(2024年版)[J].中国循环杂志,2025,40(1):6-30. |
|
|
|
